文献

J-GLOBAL ID：201802216996644206   整理番号：18A0664164

抗MDA5抗体濃度と関係なく,血清フェリチン濃度は,非ミオパチー性皮膚筋炎を伴う急速進行性間質性肺疾患の治療応答性と関連する

The Serum Ferritin Level Is Associated with the Treatment Responsivity for Rapidly Progressive Interstitial Lung Disease with Amyopathic Dermatomyositis, Irrespective of the Anti-MDA5 Antibody Level

著者 (9件)： Osawa Takeshi (Department of Respiratory Medicine, Fukujuji Hospital, Japan Anti-Tuberculosis Association, Japan) ,  Morimoto Kozo (Department of Respiratory Medicine, Fukujuji Hospital, Japan Anti-Tuberculosis Association, Japan) ,  Morimoto Kozo (Division of Clinical Research, Fukujuji Hospital, Japan Anti-Tuberculosis Association, Japan) ,  Sasaki Yuka (Department of Respiratory Medicine, Fukujuji Hospital, Japan Anti-Tuberculosis Association, Japan) ,  Matsuda Shuichi (Department of Respiratory Medicine, Fukujuji Hospital, Japan Anti-Tuberculosis Association, Japan) ,  Yamana Kazunari (Department of Respiratory Medicine, Fukujuji Hospital, Japan Anti-Tuberculosis Association, Japan) ,  Yano Ryozo (Department of Respiratory Medicine, Fukujuji Hospital, Japan Anti-Tuberculosis Association, Japan) ,  Uchiyama Takashi (Department of Respiratory Medicine, Fukujuji Hospital, Japan Anti-Tuberculosis Association, Japan) ,  Goto Hajime (Department of Respiratory Medicine, Fukujuji Hospital, Japan Anti-Tuberculosis Association, Japan)
資料名： Internal Medicine (Web)  (Internal Medicine (Web))
巻： 57  号： 3  ページ： 387-391(J-STAGE)  発行年： 2018年 
JST資料番号： U0033A  ISSN： 1349-7235  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： 日本 (JPN)  言語： 英語 (EN)

抄録/ポイント： 著者らは,臨床的に非ミオパチー性皮膚筋炎に起因する急速進行性...

シソーラス用語： ヒト ,...
準シソーラス用語： *急速進行性間質性肺疾患 ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A0664164&from=J-GLOBAL&jstjournalNo=U0033A") }}

著者キーワード (6件)： amyopathic dermatomyositis ,  抗臨床的に筋症状の無い皮膚筋炎140抗体 ,  抗メラノーマ分化関連遺伝子5抗体 ,  フェリチン ,  ポリミキシンB直接血液潅流 ,  急速進行性間質性肺疾患

分類 (1件)： 呼吸器の疾患  (GI03000Z)

引用文献 (25件)：

• 1. Sontheimer RD. Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis siné myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? J Am Acad Dermatol 46: 626-636, 2002.
• 2. Gerami P, Schope JM, McDonald L, Walling HW, Sontheimer RD. A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies. J Am Acad Dermatol 54: 597-613, 2006.
• 3. Sato S, Kuwana M. Clinically amyopathic dermatomyositis. Curr Opin Rheumatol 22: 639-643, 2010.
• 4. Fujisawa T, Hozumi H, Kono M, et al. Prognostic factors for myositis-associated interstitial lung disease. PLoS One 9: e98824, 2014.
• 5. Teruya A, Kawamura K, Ichikado K, Sato S, Yasuda Y, Yoshioka M. Successful polymyxin B hemoperfusion treatment associated with serial reduction of serum anti-CADM-140/MDA5 antibody levels in rapidly progressive interstitial lung disease with amyopathic dermatomyositis. Chest 144: 1934-1936, 2013.

タイトルに関連する用語 (7件)： 抗MDA5抗体 ,  血清フェリチン ,  ミオパチー ,  皮膚筋炎 ,  急速 ,  間質性肺疾患 ,  治療応答性